Fig. 3
From: Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway
THBS1 was targeted by miR-338-3p.(A) TargetScan was used to predict THBS1 binding sites on miR-338-3p. (B) Dual-luciferase activity analysis was performed to confirm the relationship between miR-338-3p and THBS1. **P < 0.001 vs. miR-NC. (C) THBS1 expression in normal and glioma samples was assessed. (D) THBS1 expression in primary normal human astrocytes (NHA) and glioma cells (U251 and A172) was assessed. **P < 0.001 vs. NHA. (E) Spearman’s correlation analysis showed the correlation between THBS1 expression and miR-338-3p expression in glioma tissues